Randomized Trial: Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation

Presented at the American College of Cardiology (ACC) 2019 Scientific Session.

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial – JAMA (free for a limited period)

Related Study: Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial – JAMA (free for a limited period)

Video Summary: Catheter Ablation vs Drug Therapy for Patients With Atrial Fibrillation: The CABANA Trial (free)

Editorial: Catheter Ablation for Atrial Fibrillation: Lessons Learned From CABANA (free for a limited period)

Commentary: Surgery no better than medication at preventing serious complications of atrial fibrillation – NIH News Releases (free)

Related Commentary on Twitter

BREAKING: In the CABANA Trial, catheter ablation was no different from drug therapy at reducing death, disabling stroke, serious bleeding, or cardiac arrest in patients with symptomatic atrial fibrillation https://t.co/Wg0EScwrHB #ACC19 #Afib pic.twitter.com/k9CKjuQMNp

— JAMA (@JAMA_current) March 15, 2019